[Experience of using a triple fixed combination in the treatment of patients with chronic obstructive pulmonary disease].

E V Bolotova A V Dudnikova L V Shulzhenko

Published in: Terapevticheskii arkhiv (2022)

The use of a fixed combination of vilanterol/umeclidinium bromide/fluticasone furoate for 12 months allowed to reduce the impact of the disease, improve respiratory function and quality of life in COPD patients with eosinophilia.

Keyphrases

chronic obstructive pulmonary disease
lung function
combination therapy
cystic fibrosis
air pollution
respiratory tract
replacement therapy
smoking cessation